Raymond T Keane - Net Worth and Insider Trading
Raymond T Keane Net Worth
The estimated net worth of Raymond T Keane is at least $1 Million dollars as of 2024-05-13. Raymond T Keane is the SVP General Counsel & CCO of ARIAD Pharmaceuticals Inc and owns about 62,096 shares of ARIAD Pharmaceuticals Inc (ARIA) stock worth over $1 Million. Details can be seen in Raymond T Keane's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Raymond T Keane has not made any transactions after 2013-07-18 and currently still holds the listed stock(s).
Transaction Summary of Raymond T Keane
Raymond T Keane Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Raymond T Keane owns 1 companies in total, including Cullinan Therapeutics Inc (CGEM) .
Click here to see the complete history of Raymond T Keane’s form 4 insider trades.
Insider Ownership Summary of Raymond T Keane
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CGEM | Cullinan Therapeutics Inc | 2021-01-07 | Chief Legal Officer |
Raymond T Keane Latest Holdings Summary
Raymond T Keane currently owns a total of 1 stock. Raymond T Keane owns 62,096 shares of ARIAD Pharmaceuticals Inc (ARIA) as of July 18, 2013, with a value of $1 Million.
Latest Holdings of Raymond T Keane
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARIA | ARIAD Pharmaceuticals Inc | 2013-07-18 | 62,096 | 23.99 | 1,489,683 |
Holding Weightings of Raymond T Keane
Raymond T Keane Form 4 Trading Tracker
According to the SEC Form 4 filings, Raymond T Keane has made a total of 0 transactions in ARIAD Pharmaceuticals Inc (ARIA) over the past 5 years. The most-recent trade in ARIAD Pharmaceuticals Inc is the sale of 8,000 shares on July 18, 2013, which brought Raymond T Keane around $158,320.
Insider Trading History of Raymond T Keane
- 1
Raymond T Keane Trading Performance
Raymond T Keane Ownership Network
Raymond T Keane Owned Company Details
What does Cullinan Therapeutics Inc do?
Who are the key executives at Cullinan Therapeutics Inc?
Raymond T Keane is the Chief Legal Officer of Cullinan Therapeutics Inc. Other key executives at Cullinan Therapeutics Inc include See Remarks Jennifer Michaelson , Acting Chief Business Officer Savill Corrine , and director & President and CEO Nadim Ahmed .
Cullinan Therapeutics Inc (CGEM) Insider Trades Summary
Over the past 18 months, Raymond T Keane made no insider transaction in Cullinan Therapeutics Inc (CGEM). Other recent insider transactions involving Cullinan Therapeutics Inc (CGEM) include a net sale of 83,555 shares made by Jennifer Michaelson , a net sale of 6,823 shares made by Jeffrey Trigilio , and a net sale of 3,809 shares made by Jeffrey Alan Jones .
In summary, during the past 3 months, insiders sold 63,606 shares of Cullinan Therapeutics Inc (CGEM) in total and bought 0 shares, with a net sale of 63,606 shares. During the past 18 months, 224,214 shares of Cullinan Therapeutics Inc (CGEM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 224,214 shares.
Cullinan Therapeutics Inc (CGEM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cullinan Therapeutics Inc Insider Transactions
Raymond T Keane Mailing Address
Above is the net worth, insider trading, and ownership report for Raymond T Keane. You might contact Raymond T Keane via mailing address: C/o Ariad Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
